190 related articles for article (PubMed ID: 22211897)
1. Making progress: preserving beta cells in type 1 diabetes.
Gallagher MP; Goland RS; Greenbaum CJ
Ann N Y Acad Sci; 2011 Dec; 1243():119-34. PubMed ID: 22211897
[TBL] [Abstract][Full Text] [Related]
2. Prevention versus intervention of type 1 diabetes.
Brooks-Worrell B; Palmer JP
Clin Immunol; 2013 Dec; 149(3):332-8. PubMed ID: 23803322
[TBL] [Abstract][Full Text] [Related]
3. Disease-modifying immunotherapy for the management of autoimmune diabetes.
Castro CN; Barcala Tabarrozi AE; Noguerol MA; Liberman AC; Dewey RA; Arzt E; Morelli AE; Perone MJ
Neuroimmunomodulation; 2010; 17(3):173-6. PubMed ID: 20134195
[TBL] [Abstract][Full Text] [Related]
4. New prospects for immunotherapy at diagnosis of type 1 diabetes.
Pozzilli P; Leslie RD
Diabetes Metab Res Rev; 2009 May; 25(4):299-301. PubMed ID: 19405079
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy trials for type 1 diabetes: the contribution of George Eisenbarth.
Skyler JS; Pugliese A
Diabetes Technol Ther; 2013 Jun; 15 Suppl 2(Suppl 2):S2-13-S2-20. PubMed ID: 23786294
[TBL] [Abstract][Full Text] [Related]
6. Novel therapies in the management of type I diabetes mellitus.
Ludvigsson J
Panminerva Med; 2012 Dec; 54(4):257-70. PubMed ID: 23123577
[TBL] [Abstract][Full Text] [Related]
7. Type 1 diabetes intervention trials 2007: where are we and where are we going?
Haller MJ; Gottlieb PA; Schatz DA
Curr Opin Endocrinol Diabetes Obes; 2007 Aug; 14(4):283-7. PubMed ID: 17940453
[TBL] [Abstract][Full Text] [Related]
8. B cell-directed therapies in type 1 diabetes.
Mariño E; Silveira PA; Stolp J; Grey ST
Trends Immunol; 2011 Jun; 32(6):287-94. PubMed ID: 21531625
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy of type 1 diabetes--how to rationally prioritize combination therapies in T1D.
Boettler T; von Herrath M
Int Immunopharmacol; 2010 Dec; 10(12):1491-5. PubMed ID: 20667487
[TBL] [Abstract][Full Text] [Related]
10. New therapies aimed at the preservation or restoration of beta cell function in type 1 diabetes.
Keymeulen B
Acta Clin Belg; 2006; 61(5):275-85. PubMed ID: 17240745
[TBL] [Abstract][Full Text] [Related]
11. Therapies aimed at preservation or restoration of beta cell function in type 1 diabetes.
Keymeulen B
Verh K Acad Geneeskd Belg; 2008; 70(2):85-103. PubMed ID: 18630722
[TBL] [Abstract][Full Text] [Related]
12. [Immunological intervention to preserve beta-cell function in type 1 diabetes].
Schloot NC
Dtsch Med Wochenschr; 2010 May; 135(18):915-21. PubMed ID: 20425677
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy for the prevention and treatment of type 1 diabetes.
Goudy KS; Tisch R
Int Rev Immunol; 2005; 24(5-6):307-26. PubMed ID: 16318984
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the age-at-onset heterogeneity in type 1 diabetes through mathematical modeling.
Wang X; He Z; Ghosh S
Math Biosci; 2006 Sep; 203(1):79-99. PubMed ID: 16723139
[TBL] [Abstract][Full Text] [Related]
15. Tackling type 1 diabetes: new immune-modulating drugs attack the root cause.
Shekhar C
Chem Biol; 2007 Dec; 14(12):1305-6. PubMed ID: 18096495
[No Abstract] [Full Text] [Related]
16. Immune intervention for type 1 diabetes mellitus.
Skyler JS
Int J Clin Pract Suppl; 2011 Feb; (170):61-70. PubMed ID: 21323814
[TBL] [Abstract][Full Text] [Related]
17. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
Serreze DV; Marron MP; Dilorenzo TP
Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
[TBL] [Abstract][Full Text] [Related]
18. Do immunotherapy and beta cell replacement play a synergistic role in the treatment of type 1 diabetes?
Li DS; Warnock GL; Tu HJ; Ao Z; He Z; Lu H; Dai LJ
Life Sci; 2009 Oct; 85(15-16):549-56. PubMed ID: 19747492
[TBL] [Abstract][Full Text] [Related]
19. Toward a cure for type 1 diabetes mellitus: diabetes-suppressive dendritic cells and beyond.
Giannoukakis N; Phillips B; Trucco M
Pediatr Diabetes; 2008 Jun; 9(3 Pt 2):4-13. PubMed ID: 18540865
[TBL] [Abstract][Full Text] [Related]
20. Diabetes technology and treatments in the paediatric age group.
Shalitin S; Peter Chase H
Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
